EUVIMEDDescoperă EUVIMED
Crossref

Protective Role of miR‐3909 Against Propofol‐Induced Neurotoxicity Through the Regulation of Polymerase I and Transcript Release Factor

Xiangyu Lu, Yuanzhu Li, Haitao Lou, Zhiqiang Feng, Chuancheng Zong

Synapse · 2026-03 · 80 (2)

DOI: 10.1002/syn.70041 ↗

At a glance

Journal article in Synapse, published online on 2026-02-28. Written by Xiangyu Lu and 4 co-authors. Institution: Surgical Anesthesia Center, Affiliated HongQi Hospital of Mudanjiang Medical University, Mudanjiang, China. Major MEDLINE topics: Propofol, MicroRNAs, Neurons, Anesthetics, Intravenous. 32 references.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Propofol (PPF), a commonly employed clinical anesthetic, has elicited growing concern due to its associated neurotoxic effects. However, the functional role and mechanistic insights of microRNA‐3909 (miR‐3909) in PPF‐induced neurotoxicity remain unexplored. This study sought to elucidate the expression of miR‐3909 and its underlying molecular mechanisms in the context of PPF‐induced neurotoxicity. An in vitro model of PPF neurotoxicity was established using SH‐SY5Y cells (PPF‐SH‐SY5Y). Initial assessments via cell counting kit‐8 (CCK‐8) and reverse transcription‐quantitative polymerase chain reaction (RT‐qPCR) demonstrated that treatment with 50 µM PPF significantly reduced cell viability and downregulated miR‐3909 expression. Subsequent functional assays revealed that overexpression of miR‐3909 effectively alleviated PPF‐induced neurotoxicity, as evidenced by enhanced cell viability, suppression of apoptosis, reduced lactate dehydrogenase (LDH) release, and decreased reactive oxygen species (ROS) levels. Mechanistic investigations, including a dual‐luciferase reporter assay, validated that miR‐3909 directly targets and negatively regulates the expression of polymerase I and transcript release factor (PTRF). Notably, PTRF was significantly upregulated in PPF‐SH‐SY5Y cells, and overexpression of PTRF substantially counteracted the neuroprotective effects mediated by miR‐3909. Collectively, these findings indicate that miR‐3909 alleviates propofol‐induced neurotoxicity by targeting PTRF, thereby providing a potential therapeutic target for this condition.

Subjects

MeSH terms (MEDLINE)

PropofolMicroRNAsNeuronsAnesthetics, IntravenousHumansCell Line, TumorCell SurvivalApoptosisReactive Oxygen Species

Author keywords

PTRFSH‐SY5YmiR‐3909neurotoxicityoxidative stresspropofol

Substances

PropofolMicroRNAsReactive Oxygen SpeciesAnesthetics, Intravenous

Authors and institutions

  • Surgical Anesthesia Center, Affiliated HongQi Hospital of Mudanjiang Medical University, Mudanjiang, China.
  • Department of Anesthesiology, The 63600 Hospital of PLA, Jiuquan, China.
  • Department of Pharmacy, Zhuji Maternal and Child Health Hospital, Zhuji, China.
  • Department of Anesthesiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, Liaoning, China.
  • Department of Anesthesiology, The Eighth Hospital of Wuhan, Wuhan, China.

Cite

APA

Lu, X., Li, Y., Lou, H., Feng, Z., & Zong, C. (2026). Protective Role of miR‐3909 Against Propofol‐Induced Neurotoxicity Through the Regulation of Polymerase I and Transcript Release Factor. Synapse, 80(2). https://doi.org/10.1002/syn.70041

Vancouver

Lu X, Li Y, Lou H, Feng Z, Zong C. Protective Role of miR‐3909 Against Propofol‐Induced Neurotoxicity Through the Regulation of Polymerase I and Transcript Release Factor. Synapse. 2026;80(2). doi:10.1002/syn.70041

BibTeX
@article{Lu2026,
  author = {Lu, Xiangyu and Li, Yuanzhu and Lou, Haitao and Feng, Zhiqiang and Zong, Chuancheng},
  title = {Protective Role of miR‐3909 Against Propofol‐Induced Neurotoxicity Through the Regulation of Polymerase I and Transcript Release Factor},
  journal = {Synapse},
  year = {2026},
  volume = {80},
  number = {2},
  doi = {10.1002/syn.70041}
}
Start for free →